Mainebiz posts release about Neuright being awarded grant

Mainebiz shared a University of Maine media release about the university biotech spinoff Neuright, Inc. being awarded $225,000 through the National Science Foundation’s Small Business Technology Transfer program. Magdalena Blaszkiewicz, who earned a doctoral degree in biomedical sciences, and Kristy Townsend, associate professor of neurobiology, co-founded the company. The goal is to develop diagnostic and therapeutic options for peripheral neuropathy, a condition in which nerve fibers die back from the skin. Diabetes, which affects about 34 million Americans, is the leading cause of peripheral neuropathy. Early intervention and treatment can help people minimize and manage the often-debilitating effects. The name Neuright comes from the company’s goal: to “make neuropathy right in all its forms.”